# Anandamide (ethanol solution), endogenous cannabinoid > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/anandamide-ethanol-solution-endogenous-cannabinoid/ > **Published:** 2026-07-21T07:16:20-04:00 | **Last Modified / Clinically Audited:** 2026-09-09T10:03:25-04:00 > **Clinical Summary:** Anandamide research reagent discontinued. Clinical impact on endocannabinoid system research and cannabinoid pharmacology explained. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologySafetyMental HealthAnxietyPainDosing Dr. Caplan’s Take “This appears to be a discontinued product listing rather than clinical evidence, so it doesn’t inform our treatment decisions directly. What we do know from peer-reviewed research is that anandamide, our body’s own cannabinoid, plays a role in pain and mood regulation, but we’re still early in understanding how exogenous cannabinoids might therapeutically modulate these pathways in humans.” Clinical Perspective 🧠 While this notice reflects the discontinuation of a commercial anandamide preparation, the clinical relevance of the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) remains significant for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). Anandamide, an endogenous ligand of [cannabinoid receptors](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/), is involved in pain modulation, mood regulation, and appetite control, making it therapeutically interesting for conditions ranging from [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) to anxiety. However, the unavailability of this particular research reagent highlights a broader challenge in translating endocannabinoid science into [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/): the difficulty in developing stable, bioavailable pharmacologic agents targeting this system. Clinicians should recognize that while cannabis contains exogenous cannabinoids that may influence endocannabinoid signaling, the complexity of the system—including tissue-specific receptor distribution, metabolic variability, and potential drug interactions—means patient outcomes remain highly variable and context-dependent. When counseling patients interested in 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Anandamide%20%28ethanol%20solution%29%2C%20endogenous%20cannabinoid%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70925)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70925)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Anandamide%20%28ethanol%20solution%29%2C%20endogenous%20cannabinoid%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D70925)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.abcam.com/ko/products/biochemicals/anandamide-ethanol-solution-endogenous-cannabinoid-ab120087](https://www.abcam.com/ko/products/biochemicals/anandamide-ethanol-solution-endogenous-cannabinoid-ab120087) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).